Yuhan advises life sciences companies on a wide range of third-party commercial transactions, including collaboration and license agreements. She also counsels clients on intellectual property matters within the broader context of corporate transactions, such as M&A.
Capstan Therapeutics Announces up to $2.1 Billion Acquisition by AbbVie
June 30, 2025
Cooley advised Capstan Therapeutics, a clinical-stage biotechnology company with a mission to multiply therapeutic possibilities for patients through targeted in vivo RNA technologies, on its definitive agreement to be acquired by AbbVie.